Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Moyle · SciRah

Researcher profile · Semantic Scholar

G. Moyle

Share profile

G. Moyle — researcher profile on SciRah

h-index: 49
Works: 296
Citations: 9,081

Most-cited papers

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
E. Lefebvre, G. Moyle, R. Reshef, Lee P. Richman +11 more
2016PLoS ONE298 citations Open access
Semantic Scholar
Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1–Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study
J. Molina, J. Andrade-Villanueva, J. Echevarría, P. Chetchotisakd +10 more
2010Journal of Acquired Immune Deficiency Syndromes274 citations Open access
Semantic Scholar
Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, HIV-1–Infected Adults: 48-Week Results From the ASSERT Study
F. Post, G. Moyle, H. Stellbrink, P. Domingo +11 more
2010Journal of Acquired Immune Deficiency Syndromes206 citations Open access
Semantic Scholar
Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study
E. Berkowitz, G. Moyle, H. Stellbrink, D. Schürmann +12 more
2014Journal of Infectious Diseases195 citations Open access
Semantic Scholar
Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data
M. Cruciani, V. Zanichelli, G. Serpelloni, O. Bosco +5 more
2011AIDS (London)157 citations Open access
Semantic Scholar
Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.
J. Gallant, E. Koenig, J. Andrade-Villanueva, P. Chetchotisakd +12 more
2013Journal of Infectious Diseases122 citations Open access
Semantic Scholar
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.
R. Pollard, J. Rockstroh, G. Pantaleo, D. Asmuth +25 more
2014Lancet. Infectious Diseases (Print)95 citations Open access
Semantic Scholar
A Randomized, Double-Blind, Controlled Study of NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-Associated Distal Sensory Polyneuropathy
D. Clifford, D. Simpson, Stephen J. Brown, G. Moyle +4 more
2012Journal of Acquired Immune Deficiency Syndromes91 citations Open access
Semantic Scholar
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.
J. Falutz, J. Mamputu, D. Potvin, G. Moyle +5 more
2010Journal of Clinical Endocrinology and Metabolism89 citations Open access
Semantic Scholar
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk
J. Gatell, L. Assoumou, G. Moyle, L. Waters +13 more
2017AIDS (London)80 citations Open access
Semantic Scholar
Effects of Tesamorelin, a Growth Hormone–Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension
J. Falutz, D. Potvin, J. Mamputu, H. Assaad +9 more
2010Journal of Acquired Immune Deficiency Syndromes77 citations Open access
Semantic Scholar
Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1.
G. Moyle, E. Dejesus, M. Boffito, R. Wong +6 more
2009Clinical Infectious Diseases76 citations Open access
Semantic Scholar
96-Week Results of Abacavir/Lamivudine versus Tenofovir/Emtricitabine, plus Efavirenz, in Antiretroviral-Naive, HIV-1-Infected Adults: Assert Study
G. Moyle, H. Stellbrink, J. Compston, C. Orkin +6 more
2013Antiviral Therapy67 citations
Semantic Scholar
HIV integrase inhibitors: a new era in the treatment of HIV
J. Blanco, G. Whitlock, A. Milinkovic, G. Moyle
2015Expert Opinion on Pharmacotherapy63 citations
Semantic Scholar
NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials
Stephen J. Brown, D. Simpson, G. Moyle, B. Brew +6 more
2013AIDS Research and Therapy58 citations Open access
Semantic Scholar
Increased Dolutegravir Peak Concentrations in People Living With Human Immunodeficiency Virus Aged 60 and Over, and Analysis of Sleep Quality and Cognition
Emilie R. Elliot, Xinzhu Wang, Suveer Singh, Bryony Simmons +6 more
2019Clinical Infectious Diseases56 citations Open access
Semantic Scholar
Tenofovir, Emtricitabine Intracellular and Plasma, and Efavirenz Plasma Concentration Decay Following Drug Intake Cessation: Implications for HIV Treatment and Prevention
A. Jackson, G. Moyle, V. Watson, J. Tjia +5 more
2013Journal of Acquired Immune Deficiency Syndromes55 citations Open access
Semantic Scholar
Steady-State Pharmacokinetics of Abacavir in Plasma and Intracellular Carbovir Triphosphate following Administration of Abacavir at 600 Milligrams Once Daily and 300 Milligrams Twice Daily in Human Immunodeficiency Virus-Infected Subjects
G. Moyle, M. Boffito, C. Fletcher, C. Higgs +6 more
2009Antimicrobial Agents and Chemotherapy52 citations Open access
Semantic Scholar
Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz
V. Cooper, G. Moyle, M. Fisher, G. Reilly +3 more
2011AIDS Care48 citations Open access
Semantic Scholar
The effect of tenofovir disoproxil fumarate on whole-body insulin sensitivity, lipids and adipokines in healthy volunteers
P. Randell, A. Jackson, L. Zhong, Kitty Yale +1 more
2010Antiviral Therapy48 citations
Semantic Scholar
Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV
Sonia Vibhakar Patel, D. Jayaweera, K. Althoff, J. Eron +9 more
2020PLoS ONE45 citations Open access
Semantic Scholar
Pharmacokinetics of Once-Daily Darunavir-Ritonavir and Atazanavir-Ritonavir over 72 Hours following Drug Cessation
M. Boffito, A. Jackson, A. Amara, D. Back +5 more
2011Antimicrobial Agents and Chemotherapy44 citations Open access
Semantic Scholar
Phase 2a Randomized Controlled Trial of Short-Term Activity, Safety, and Pharmacokinetics of a Novel Nonnucleoside Reverse Transcriptase Inhibitor, RDEA806, in HIV-1-Positive, Antiretroviral-Naïve Subjects
G. Moyle, M. Boffito, A. Stoehr, A. Rieger +10 more
2010Antimicrobial Agents and Chemotherapy44 citations Open access
Semantic Scholar
Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach
B. Peters, F. Post, A. Wierzbicki, A. Phillips +9 more
2013HIV Medicine40 citations
Semantic Scholar
Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake.
Emilie R. Elliot, A. Amara, A. Jackson, G. Moyle +5 more
2016Journal of Antimicrobial Chemotherapy37 citations
Semantic Scholar
Clinical Significance of Hyperbilirubinemia Among HIV-1–Infected Patients Treated with Atazanavir/Ritonavir Through 96 Weeks in the CASTLE Study
C. Mcdonald, J. Uy, Wen-Hua Hu, Victoria Wirtz +5 more
2012AIDS Patients Care and STDs35 citations Open access
Semantic Scholar
Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infection.
G. Moyle, M. Moutschen, E. Martínez, P. Domingo +4 more
2010AIDS Reviews35 citations
Semantic Scholar
The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial.
B. Peters, A. Wierzbicki, G. Moyle, D. Nair +1 more
2012Clinical Therapeutics33 citations
Semantic Scholar
A Randomized Comparative Trial of Continued Abacavir/Lamivudine plus Efavirenz or Replacement with Efavirenz/Emtricitabine/Tenofovir DF in Hypercholesterolemic HIV-1 Infected Individuals
G. Moyle, C. Orkin, M. Fisher, J. Dhar +5 more
2015PLoS ONE31 citations Open access
Semantic Scholar
Sequential Population Pharmacokinetic Modeling of Lopinavir and Ritonavir in Healthy Volunteers and Assessment of Different Dosing Strategies
L. Dickinson, M. Boffito, D. Back, L. Else +6 more
2011Antimicrobial Agents and Chemotherapy30 citations Open access
Semantic Scholar
Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake Cessation
L. Dickinson, H. Yapa, A. Jackson, G. Moyle +7 more
2015Antimicrobial Agents and Chemotherapy25 citations Open access
Semantic Scholar
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV.
A. González-Cordón, L. Assoumou, G. Moyle, L. Waters +15 more
2021Journal of Antimicrobial Chemotherapy24 citations Open access
Semantic Scholar
CCR5 Antagonism Impacts Vaccination Response and Immune Profile in HIV-1 Infection
Samantha J. Westrop, G. Moyle, A. Jackson, M. Nelson +2 more
2012Molecular Medicine23 citations Open access
Semantic Scholar
Virological efficacy of abacavir: systematic review and meta-analysis.
M. Cruciani, C. Mengoli, M. Malena, G. Serpelloni +3 more
2014Journal of Antimicrobial Chemotherapy20 citations
Semantic Scholar
FRAX assessment in people ageing with HIV
M. Mazzitelli, Pereira Branca Isabel, T. Muramatsu, M. Chirwa +4 more
2021HIV Medicine19 citations
Semantic Scholar
Factors associated with overweight/obesity in a cohort of people living with HIV over 50 years of age
M. Mazzitelli, Branca Isabel Pereira, G. Moyle, D. Asboe +3 more
2021AIDS Care17 citations
Semantic Scholar
Genetic influence of ABCG2, UGT1A1 and NR1I2 on dolutegravir plasma pharmacokinetics.
Emilie R. Elliot, Megan Neary, L. Else, S. Khoo +6 more
2020Journal of Antimicrobial Chemotherapy17 citations
Semantic Scholar
Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infection.
Anna A. Herasimtschuk, Jocelyn S. Downey, M. Nelson, G. Moyle +6 more
2014Vaccine17 citations Open access
Semantic Scholar
Incidence of hypertension and blood pressure changes in persons with HIV at high risk for cardiovascular disease switching from boosted protease inhibitors to dolutegravir: a post-hoc analysis of the 96-week randomised NEAT-022 trial.
Abiu Sempere, L. Assoumou, A. González-Cordón, L. Waters +20 more
2023Clinical Infectious Diseases16 citations
Semantic Scholar
Use of Coronary Artery Calcium Scoring to improve cardiovascular risk stratification and guide decisions to start statin therapy in People living with HIV.
Branca Pereira, Maria Mazzitelli, A. Milinkovic, G. Moyle +7 more
2020Journal of Acquired Immune Deficiency Syndromes15 citations Open access
Semantic Scholar
Pharmacokinetics of the co-administration of boceprevir and St John's wort to male and female healthy volunteers.
A. Jackson, A. D'Avolio, G. Moyle, S. Bonora +6 more
2014Journal of Antimicrobial Chemotherapy15 citations Open access
Semantic Scholar
Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor
M. Fisher, C. Mcdonald, G. Moyle, C. Martorell +8 more
2014Journal of the International AIDS Society15 citations Open access
Semantic Scholar
A Randomized Comparative 96-Week Trial of Boosted Atazanavir versus Continued Boosted Protease Inhibitor in HIV-1 Patients with Abdominal Adiposity
G. Moyle, J. Andrade-Villanueva, P. Girard, A. Antinori +8 more
2012Antiviral Therapy15 citations
Semantic Scholar
Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men
P. Randell, A. Jackson, M. Boffito, D. Back +4 more
2010Antiviral Therapy14 citations Open access
Semantic Scholar
Changes in Bone Mineral Density After 96 Weeks of Treatment With Atazanavir/Ritonavir or Lopinavir/Ritonavir Plus Tenofovir DF/Emtricitabine in Treatment-Naive Patients With HIV-1 Infection: The CASTLE Body Composition Substudy
G. Moyle, H. Hardy, A. Farajallah, S. McGrath +2 more
2015Journal of Acquired Immune Deficiency Syndromes13 citations Open access
Semantic Scholar
Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study
T. Barber, L. Bansi, A. Pozniak, D. Asboe +8 more
2017International Journal of STD and AIDS10 citations Open access
Semantic Scholar
Comparison of Body Composition Changes Between Atazanavir/Ritonavir and Lopinavir/Ritonavir Each in Combination with Tenofovir/Emtricitabine in Antiretroviral-Naïve Patients with HIV-1 Infection
G. Moyle, H. Hardy, A. Farajallah, Michelle DeGrosky +1 more
2014Clinical drug investigation10 citations
Semantic Scholar
The Emerging Roles of Non-Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Therapy
G. Moyle
2012Drugs10 citations
Semantic Scholar
Pharmacokinetics of once-daily doravirine over 72 h following drug cessation.
Xinzhu Wang, A. Milinkovic, Branca Pereira, G. Moyle +6 more
2020Journal of Antimicrobial Chemotherapy9 citations
Semantic Scholar
Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge
Emilie R. Elliot, A. Amara, N. Pagani, L. Else +5 more
2017Journal of Antimicrobial Chemotherapy9 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Boffito×16
Invite
M. Boffito — researcher profile on SciRah
A. Jackson×8
Invite
A. Jackson — researcher profile on SciRah
A. Pozniak×7
Invite
A. Pozniak — researcher profile on SciRah
D. Back×7
Invite
D. Back — researcher profile on SciRah

×6

Invite

H. Stellbrink — researcher profile on SciRah

Invite

P. Domingo — researcher profile on SciRah

Invite

M. Fisher — researcher profile on SciRah

Invite

S. Khoo — researcher profile on SciRah

Invite

L. Else — researcher profile on SciRah

A. Milinkovic×5

Invite

A. Milinkovic — researcher profile on SciRah

Invite

S. Esser — researcher profile on SciRah

Invite

C. Orkin — researcher profile on SciRah